Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Derazantinib
Trade Name
Synonyms ARQ 087
Drug Descriptions

Derazantinib (ARQ 087) is an ATP-competitive multi-kinase inhibitor with activity against Fgfr 1/2, FGFR fusions, Arg, Lck, and Kit, which prevents cell proliferation and angiogenesis (PMID: 27627808).

DrugClasses FGFR1 Inhibitor 28 FGFR2 Inhibitor 22 KIT Inhibitor 57 LCK Inhibitor 6
CAS Registry Number 1234356-69-4
NCIT ID C104267


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Atezolizumab + Derazantinib Atezolizumab Derazantinib 0 3
Derazantinib Derazantinib 15 4
Derazantinib + Paclitaxel + Ramucirumab Derazantinib Paclitaxel Ramucirumab 0 1

Additional content available in CKB BOOST